Gilead’s stock falls on remdesivir, Eli Lilly begins human study of possible COVID-19 treatment

Gilead's stock falls on remdesivir, Eli Lilly begins human study of possible COVID-19 treatment Eli Lilly announced the company has started an early-stage trial to test its potential treatment for coronavirus. Yahoo Finance’s Anjalee Khemlani breaks down the latest developments.

from Yahoo Finance https://ift.tt/2MgArtd

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *